Skip to main content
Clinical Trials/NL-OMON30285
NL-OMON30285
Not yet recruiting
Not Applicable

Pituitary dysfunction after traumatic brain injury: a new challenge in neurotraumatology - Pituitary dysfunction after traumatic brain injury

niversitair Medisch Centrum Sint Radboud0 sites600 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
traumatologische aandoeningen
Sponsor
niversitair Medisch Centrum Sint Radboud
Enrollment
600
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • 1\. All patients who visit the emergency department with a mild, a moderate or a severe traumatic brain injury. (Mild traumatic brain injury is defined as a history of impact to the head and a Glasgow Coma Scale score (GCS) 13\-15 at entry in the emergency room, moderate traumatic brain injury is defined as a GCS 9\-12 at entry in the emergency room, and severe traumatic brain injury is defined as a GCS \<\= 8 at entry in the emergency room)
  • 2\. Initial trauma occurred less than 24 hours before visiting the Emergency Department.
  • 3\. Age \>\= 18 years and \<\= 65 years

Exclusion Criteria

  • 1\. Age \> 65 years or \< 18 years
  • 2\. No oral or written informed consent by patient or proxy
  • 3\. Pre\-existent neuro\-endocrine disorder
  • 4\. Instable infiltrative disease in the hypothalamus/pituitary region (eg sarcoidosis, tumour metastasis)
  • 5\. BMI \>30 kg/m2
  • 6\. Pregnancy or wish for pregnancy during the study period women, lactation
  • 7\. Co\-existent disease with decreased life expectancy, especially active malignant tumor
  • 8\. Chronic alcohol or drug abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials